1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Diabetic Retinopathy - Patient Advocate Foundation Co-Pay Relief Program is sponsored by Patient Advocate Foundation. This fund provides financial assistance for underinsured individuals living with diabetic retinopathy to access critical treatment, covering co-pay, co-insurance, deductibles, office visits, and medical insurance premiums. Currently closed to new applications but accepts waitlist sign-ups.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Underinsured individuals with a diagnosis of diabetic retinopathy, meeting household income requirements (400% or less of Federal Poverty Guideline, adjusted for Cost of Living Index and household size), and having Medicare, Medicaid, or Military Benefits. Must reside and receive treatment in the United States. Confirm the full requirements in the official notice before applying.
The current listing shows up to $4,000 Per Year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Diabetic Retinopathy - Patient Advocate Foundation Co-Pay Relief Program is funded by Patient Advocate Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
PCORI launched five simultaneous research funding tracks with $120 million in direct costs for pragmatic studies. Why this non-NIH funder deserves a place in your grant strategy.
Read articleARPA-H is funding the first agentic AI system that can prescribe medications, monitor patients 24/7, and manage heart disease autonomously. Here is what applicants need to know.
Read articleThe $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read article